03:21
An interview with Stephanie Niven, Portfolio Manager at Ninety One
07:48
Jayasree K. Iyer unpacks the 2024 Access to Medicine Index findings on CNBC Africa
01:00:38
Webinar: Mobilising pharma to act on the AMR Political Declaration
08:09
2024 Access to Medicine Index: A deep dive with the Foundation's CEO, Jayasree K. Iyer
07:11
Jayasree K. Iyer, CEO, speaking at the UNGA 2024 High-Level Meeting on AMR
08:37
Jayasree K. Iyer discusses the role of pharma companies in closing health gaps, on CNBC Africa
02:24
How is the pharma industry addressing patient reach?
03:05
An interview with Fiona Olivier, Sanofi
03:05
An interview with Carissa Vados, Novo Nordisk
03:27
Creating impact: Access to Medicine Foundation
04:05
An interview with Dr Claus Runge, Bayer Pharmaceuticals
02:29
How can pharma get the few promising drugs in development to patients battling superbugs?
05:37
An interview with Richard Neci Cizungu, Executive Director of the Ecumenical Pharmaceutical Network
01:57
World TB Day 2024: A message from Claudia Martínez, Head of Research
02:26
Interview with Boehringer Ingelheim's Maria Lucia Tereno and Dr Ina Witte
01:55
Em conversa com Mariângela Simão, Diretora-Presidente do Instituto Todos pela Saúde
02:14
An interview with Mariângela Simão, Director-President of the Instituto Todos pela Saúde
04:48
An interview with Michael Oberreiter, Roche, and Pritha Paul, Biocon Biologics Limited
44:37
Fireside chat on ensuring availability of essential medicines for all
51:51
Webinar: The critical role of responsible manufacturing in addressing AMR: A path forward
51:46
Fireside chat on promoting holistic access to essential diabetes care products
09:03
Jayasree K. Iyer on CNBC Africa: the role of the generics industry in expanding access to medicine
04:24
An interview with Dr Iain Barton, Founding Principal of Health 4 Development
00:24
Shalini Jayasekar-Zürn on the Analytical Framework for Generic & Biosimilar Medicine Manufacturers
02:47
An interview with Robert Yates, Executive Director of Chatham House's Centre for Universal Health
02:25
What are generic & biosimilar medicine manufacturers doing to expand access to their products?
35:25
Fireside chat on scaling up access to glucose self-monitoring devices and associated commodities
04:48
An interview with James Reid, Program Officer, Type 1 Diabetes at The Helmsley Charitable Trust
24:32
Fireside chat: Manufacturing responsibly to curb AMR
02:12
What steps are companies taking to help curb AMR by manufacturing responsibly?
04:43
Dr Linda-Gail Bekker on what more can companies do to scale up access
03:24
What global health stakeholders say about the impact of our work
03:20
An interview with Dr Ebere Okereke, CEO at Africa Public Health Foundation
04:18
An interview with Frank Wagemans, Senior Engagement Specialist at Achmea IM
03:34
An interview with Esteban Burrone, Head of Policy, Strategy and Market Access at MPP
02:58
An interview with Dr Luis Pizarro, Executive Director of DNDi
03:56
An interview with Dr Zainab Shinkafi Bagudu, CEO at Medicaid Cancer Foundation
10:43
An interview with Dr Linda-Gail Bekker, CEO at Desmond Tutu Health Foundation
05:43
An interview with Shalini Jayasekar-Zürn, Senior Advocacy Manager at UICC
03:34
Coming soon: What are gas companies doing to scale up access to liquid medical oxygen?
44:44
Fireside chat: Scaling up access to insulin for people living in low- and middle-income countries
04:21
An interview with Dr Joseph Saba, Chief Executive Officer at Axios International
37:00
Fireside chat on the role of generic and biosimilar medicine manufacturers in scaling up access
01:42
How can generic and biosimilar medicine manufacturers scale up access to medicine?
02:32
Fatema Rafiqi on the importance of publicly sharing surveillance data to curb AMR
07:25
Jayasree K. Iyer talks access to insulin on CNBC Africa
01:28:37
2022 Access to Medicine Index launch event
01:00:22
Webinar | Sustainable access for existing antibiotics: Focus on market challenges
02:47
Access to Medicine Foundation's CEO, Jayasree K. Iyer: Join us in taking access to the next level
28:32
Fireside chat: access to insulin in low- and middle-income countries
02:31
2018 WEF panel on empowering pharma to make change
01:13
Bill Gates on the significance of the Access to Medicine Index at the 2018 WEF, Davos
03:13
Jayasree K. Iyer over antibioticaresistentie in het NOS Journaal
01:00:52
Jayasree K. Iyer on A New Era for Global Health at the World Economic Forum
05:13
Jayasree K. Iyer on pharma R&D priorities to improve access to medicine - BBC World Service
11:56
FT Panel on 'Pharma in The World's Growth Markets'
05:22
Africa 54 talks to Jayasree K. Iyer about pharma activities in Africa
01:07
NOS Journaal rapporteert over de resultaten van de 2016 Access to Medicine Index
01:24
Bill Gates explains the importance of the Access to Medicine Index at the Clinton Foundation
00:48
Dr. Margaret Chan about the 2012 Access to Medicine Index findings at a WHO/WIPO/WTO symposium
X
About
The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. We use the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products.
Tags